Background: Interleukin (IL) 10 is a potent anti-inflammatory cytokine. Disruption of the IL-I0 gene in C57/Black6 rnice results in enterocolitis in the presence of intestinal bacteria. This study investigated gut mucosal barrier function sequentially during the development of colitis in this modelo Methods: Animals were bred in specific pathogen-free conditions and transferred to convencional housing at 4weeks. Mice were evaluated at 6,8,10,12,14 and 15weeks ofage. Barrler function was assessed by measuring intestinal permeability and antibody response to systernic endotoxaernia (antibody to the core glycolipid region of lipopolysaccharide; EndoCAb). Colons were harvested and a histological injury score (IllS) was calculated. Results: The ms increased progressively until 12 weeks, with an associated increase in intestinal permeability, and irnmunoglobulin (Ig) M and IgG EndoCAb. The ms correlated positively with both intestinal permeability and IgM and IgG EndoCAb. Intestinal permeability showed a positive correlation with EndoCAb. Conclusion: n.-IO knockout rnice develop coli*1h an associated disturbance in gut mucosal barrier function, as measured by increased ~ermeability and endotoxaernia. The colitis found in the IL-I0 knockout mouse
Introduction
Despite extensive research into Crohn's disease and ulcerative colitis the aetiology, pathogenesis and natural history of inflarnmatory bowel disease (IBD) remain poorly understood. There is evidence that genetic, environmental and immunological factors are involved in the disease processl. Recently there has been renewed interest in the role played by luminal factors, most notably enteric bacteria, in the onset and perpetuation of the disease2.
The complexity of IBD is not easily reproduced in simple laboratory models such as tissue culture systems3, Experimental animal models allow study of the irnmunological and genetic components of colonic inflarnmation and their interaction3. They also provide an opportunity to investigate the early stages of the disease process and to evaluate novel therapeutic agents. A suitable model should be similar to the human disease. It should arise spontaneously, have the same aetiology and pathogenesis as human IBD, have a similar spectrum and be responsive to similar therapeutic agents4. While animal models provide information relevant to human disease and complement studies in IBD, they can never replace clinical trials.
A number of genetically engineered spontaneous models of colitis have been developed recendy which have several features in cornmon with human Crohn's. disease or ulcerative colitis5-7. Kühn et al.8 developed one of these models in 1993. Using gene targeting they developed the interleukin (IL) 10 gene-deficient mouse. Unless kept in germ-free conditions these animals develop chronic transmural enterocolitis with mucosal hyperplasia, granulomas, increased numbers of crypt cells, pseudopolyp formation, inflarnmatory cell response and aberrant expression of major histocompatibility complex class 11 antigens on the intestinal epithelia8. This inflarnmation has been well characterized in severa! strains of mouse in which the IL-10 gene has been deleted9. It bears a close resemblance to human Crohn's disease in particular, although they cannot be equated.
Disrurbed gut mucosal barrier function is a feature of human IBD with increased gut permeabilityl0 and endotoxaemia 11. The purpose of this srudy was to investigate gut barrier function in the IL-IO knockout mouse model of colitis and its relationship to colonic inflammation. colon to the centre and the caecum to the periphery, and placed in containers of 10 per cent fonnyl saline until estimation of the histological score by a pathologist. Colons were embedded in paraffin, sectioned longitudinally, and stained with haematoxylin and eosin (Fig. 1 ). Slides were examined and assigned a histological injury score (HIS) corresponding to the severity of inflammation observed, using a validated scoring system modified from those used by Saverymuttu etal. 13 The study was carried out under the regulations of the United Kingdom Animals (Scientific Procedures) Act 1986. Breeding pairs ofIL-10 knockout mice from a C57/Black6 background were obtained from Bantin and Kingham (HuII, UK). These animals had been bom, raised and transported in specific pathogen-free (SPF) conditions. Breeding pairs were housed in SPF isolators (Mordun, Edinburgh, UK). Litters bom in the isolator were weaned at approximately 3 weeks of age and then transferred to convencional conditions at 4weeks old. Mice were weighed twice weekly from this time. Six animals were studied at 6, 8, 10,12, 14and 15weeksofage.
Intestinal permeability was assessed with the technique described by Ryan et 01.12, using carbon-14-radiolabelled polyethylene glycol 4000 (pEG). Radiolabelled PEG solution (0.1 mI) was administered to each animal by gavage robe 2~ before termination of the experimento Irnrnediately thereafter the animals were anaesthetized using Hypnorm (Janssen, Beerse, Belgium) and midazolam. A 4/0 Ethilon (Ethicon, Edinburgh, UK) circurnferential anal purse-strlng suture was inserted to prevent mixing of liquid faeces with urine. Diuresis was induced by subcutaneous injection of 2 mI normal saline (Baxter, Belfast, UK). Animals were then placed in metabolic cages and the urine was collected for 24 h. Aliquots of urine were placed in scintillation vials and 0.5 mI emuIsifying scintillation fluid (Aquasafe 300 Plus; Zinsser Analytic, Maidenhead, UK) was added. The amount of radiolabelled PEG excreted in 24 h was calculated and expressed as a percentage of the total clase administered.
After collection of urine samples for 24 h the mice were anaesthetized using the method described above. Blood was collected by open cardiac puncture under aseptic conditions using al-mI syringe and placed in Eppendorf vials. Blood was spun at 450g for 15 min at 4°C. The supematant serum was then pipetted into sterile cryotubes (Nunc, Roskilde, Denmark) and frozen at -70°C until assay for irnrnunoglobulin (Ig) M and IgG antibody to the core glycolipid region of lipopolysaccharide (EndoCAb).
The peritoneal cavity was opened; the colon was dissected free of omentum and small bowel, and excised from the peritoneal reflection to the ileocaecal valve. The colon was opened longitudinally and washed free of adherent faeces. The specimen was rolled with the sigmoid (Fig. 4) . The significant rise took place between 6 and 12 weeks ofage for both IgM and IgG (bothP= 0.023) with no change between .12 and 15 weeks. There was a positive correlation between all variables measured using all data point5 (Tabk 3). Since each variable tended to increase until 12 weeks, the data from 12 weeks onwards were pooled in order to prove $at the correlation was not simply related to time. The positive correlation remained (Table 3 ).
in reasing colonic inflarnmation, which levelled at 12 weeks of ge (Fig. 2) . The HIS was higher at 10, 12 and 15 weeks th n at 6weeks (P=0.003, P=0.003 and P=0.005 respective y). Colitis was significantly greater at 12 than at 8 or 10 eeks (P = 0.006 and P = 0.049 respectively). There was no change between 12 and 15 weeks, suggesting that the in anunation had reached a plateau. The scores in each of th five sections shown in Toble 1 rase unifonnly as the in ammation progressed. testinal permeabilitywas greater at 12, 14 and 15 weeks th n at 6weeks (P=0.025, P=0.028 and P=0.019 respective y). There was an increase from 8 to 12, 14 and 15 weeks (P 0.015, P=0.033 and P=0.022 respectively) but there wa no change between 10 and 15 weeks (Fig. 3) . There was Table 3 Correlations between histological injury score, permeability and immunoglobulin M and G antibody to the core glycolipid region of lipolysaccharide liS, histological injury score; Ig, irnmunoglobulin; EndoCAb, antibody to me cace glycolipid region of lipopolysaccharide Discussion IBD is thought to be the result of a genetically determined defect in immunosuppression resulting in an overly aggressive response to ubiquitous luminal bacterial constituentsl. IL-I0 knockout mice develop chronic enterocolitis due to an aberrant immune response to normal enteric antigensl6. The model is not unique in this respecto Other models such as the IL-2 knockout mouse and HLA-/327 rat also fail to develop intestinal inflammation in germfree conditionsl7. The severity of the inflammation varies depending on the strain of mouse undergoing the gene deletion, suggesting a strong inheritable component in this particular model influencing disease susceptibility9. The inflammation is most severe in the 129/SvEvand BALB/c strains, of moderate severity in 129 X C57/Black6 outbreds and least severe in the C57/Black6 strain9. This study has confirmed that colonic inflammation in the C57/Black6 strain becomes progressively more severe as the animals age in convencional conditions. The partero of inflammation in this model is similar to the skip lesions found in patients with Crohn's disease, and the inflammation in this model, as in human IBD, is attenuated by steroid therapy18. These findings suggest that studies using the IL-IO knockout mouse mar give insight into the aetiology and pathogenesis of chronic enterocolitis, and mar be useful in evaluating potencial treatments for IBD.
There is evidence that patients with IBD have altered concentrations of bacteria in their faeces and associated with their intestinal mucosa. Bacteriological findings in patients with ulcerative colitis have ranged from normal to increased numbers of group D streptococci and coliforms to the presence of invasive Escherichia coli19-21. Increased numbers of anaerobic Gram-negative and coccoid rods have been reported in patients with small bowel Crohn's disease22-24, and increases in E. coli and Baaeroides fragilis in colonic Crohn's disease. In patients with active Crohn's disease, significant reductions in bifidobacteria and lactobacilli have been found, two species that are generally regarded as beneficial to the hoS¿s. 26 . Recent work has shown that similar alterations exist in the gastrointestinal tract DrIL-lO knockout rice, with an increase in colonic aerobes and a contrasting decrease in Laaobacillus spp. adherent to the mucosa in the Sv/Ev mode¡27. This represents a further similarity between the inflammation in this model and human IBD.
Gut mucosal barrier dysfunction is a featllre of IBD28. Two measures of gut mucosal barrier dysfunction in IBD are systemic endotoxaemia and increased intestinal permeability. This study sequentially investigated gut mucosal barrier function in IL-IO knockout rice as inflammation progressed. Colitis was found to be associated with increased intestinal permeability to a carbon-14-radiolabelled probe. This study demonstrated a direct correlation between histological injury and gut permeability in the C57/Black6 strain afilie IL-IO knockout mouse. It has recently been reported that IL-IO knockout rice on a 129/SvEv background have an increased permeability to mannitol that was present even before the onset of histological changes29. The increased permeability remained as the disease progressed29. Increased intestinal permeability to hydrophilic probes has been reported in patients with Crohn's disease30. 31 . Radiolabelled probes have demonstrated that this is also the case in ulcerative colitis32. 33 .
This study provides indirect evidence of increased systemic exposure to endotoxin as measured by increased concentrations of IgM and IgG EndoCAb in this modelo There was a positive correlation between HIS and both IgM rus study also demonstrated a positive correlation be een intestinal permeability and both IgM and IgG E doCAb. Increased permeability has been demonstrated in association with deranged measures of gut barrier crian in other animal models37-41, without demonstratin a positive correlation42. This is the first study to de onstrate conclusively a positive correlation between in stinal permeability and endotoxaemia. This is an im ortant finding, as measuring intestinal permeability is les invasive and more reproducible than measuring en otoxaemia. It also suggests that demonstration of in reased permeability in IBD is a reliable predictor of in reasing systemic exposure to intestinal bacterial antigens.
L-IO knockout mice from the C57/Black6 background de elop colitis with an associated disturbance in gut m casal barrier function, as measured by increased permeab lity and endotoxaemia. These new findings are further e dence that the IL-l O knockout model has many relevant i unological, pathological and physiological similarities to uman IBD. The IL-l O knockout mouse model of colitis is erefore suitable for use in trials of novel therapeutic ag nts that might be of benefit in IBD. Intestinal permeab lity measurements mar prove to be a reliable indicator of temic endotoxaemia in patients with IBD.
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